Edition:
United States

People: CorMedix Inc (CRMD.K)

CRMD.K on American Stock Exchange

2.65USD
28 Sep 2016
Change (% chg)

$-0.03 (-1.12%)
Prev Close
$2.68
Open
$2.70
Day's High
$2.71
Day's Low
$2.63
Volume
27,675
Avg. Vol
418,448
52-wk High
$4.54
52-wk Low
$1.15

Duffy, Matthew 

Mr. Matthew P. Duffy is Independent Director of CorMedix Inc., since November 21, 2011. Mr. Duffy is currently Managing Director at Roberts Mitani Advisors, LLC, a boutique investment bank in New York. He has also been Managing Partner and founder of Black Diamond Research, LLC, since July 2001. Further, he is a founder of Algorithm Sciences, LLC and Identic Pharmaceuticals, LLC. In addition, he is a managing member of NSIP LLC, and a member of the Executive Committee of Ellington Asset Management, LLC. He led commercial operations at Lev Pharmaceuticals, from November 2007 to October 2008. From 1995 to 2001, Mr. Duffy led the marketing group at MedImmune, Inc. Mr. Duffy holds the series 7, 63 and 65 securities licenses and received his undergraduate degree from Duke University. Among other experience, qualifications, attributes and skills, Mr. Duffy’s commercial and marketing expertise with development stage biotechnology companies led to the conclusion of our Board that he should serve as a director of our company in light of our business and structure.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --